Sorry, this entry is only available in Ukrainian.
Вас может заинтересовать:
WEB only
Negotiations on the implementation of the investment project "Establishing the production of blood preparations" in Uzbekistan were held in the Pharmaceutical industry development agency with participation of management and representatives…
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…